$10.56
0.09%
Nasdaq, Sep 02, 10:14 pm CET
ISIN
US92556V1061
Symbol
VTRS

Viatris Stock price

$10.56
+1.62 18.12% 1M
+1.23 13.18% 6M
-1.89 15.18% YTD
-1.52 12.58% 1Y
+1.11 11.75% 3Y
-5.15 32.78% 5Y
-38.06 78.28% 10Y
-7.79 42.45% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
+0.01 0.09%

Key metrics

Basic
Market capitalization
$12.3b
Enterprise Value
$24.4b
Net debt
$12.1b
Cash
$666.2m
Shares outstanding
1.2b
Valuation (TTM | estimate)
P/E
negative | 4.5
P/S
0.9 | 0.9
EV/Sales
1.7 | 1.7
EV/FCF
14.3
P/B
0.8
Dividends
DPS
$0.48
Yield 1Y | 5Y
4.6% | 2.7%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
-90.6% | 117.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$14.1b | $14.2b
EBITDA
$4.2b | $4.1b
EBIT
$1.5b | $3.7b
Net Income
$-3.5b | $2.7b
Free Cash Flow
$1.7b
Growth (TTM | estimate)
Revenue
-7.4% | -3.8%
EBITDA
0.1% | -11.7%
EBIT
3.4% | 110.7%
Net Income
-436.5% | 527.9%
Free Cash Flow
-9.4%
Margin (TTM | estimate)
Gross
40.2%
EBITDA
29.8% | 29.1%
EBIT
10.3%
Net
-24.6% | 19.1%
Free Cash Flow
12.1%
Financial Health
Equity Ratio
44.9%
Return on Equity
-3.4%
ROCE
4.6%
ROIC
4.1%
Debt/Equity
0.8
More
EPS
$-3.0
FCF per Share
$1.5
Short interest
3.6%
Employees
32k
Rev per Employee
$460.0k
Show more

Is Viatris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Viatris Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Viatris forecast:

2x Buy
13%
8x Hold
53%
5x Sell
33%

Analyst Opinions

15 Analysts have issued a Viatris forecast:

Buy
13%
Hold
53%
Sell
33%

Financial data from Viatris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
14,116 14,116
7% 7%
100%
- Direct Costs 8,448 8,448
3% 3%
60%
5,668 5,668
13% 13%
40%
- Selling and Administrative Expenses 3,376 3,376
22% 22%
24%
- Research and Development Expense 841 841
3% 3%
6%
4,210 4,210
0% 0%
30%
- Depreciation and Amortization 2,759 2,759
2% 2%
20%
EBIT (Operating Income) EBIT 1,451 1,451
3% 3%
10%
Net Profit -3,468 -3,468
436% 436%
-25%

In millions USD.

Don't miss a Thing! We will send you all news about Viatris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viatris Stock News

Neutral
PRNewsWire
15 days ago
PITTSBURGH , Aug. 19, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the appointment of Andrew Enrietti as Chief Administrative and Transformation Officer. In this newly created role, Enrietti will oversee the company's Human Relations, Business Transformation, Information Technology, Information Security, Global Transportation and Security, and G...
Positive
Seeking Alpha
19 days ago
Many high-yield S&P 500 stocks are risky, but 19 'safer' dividend dogs have strong free cash flow to support payouts and are worth considering. Analyst forecasts suggest the top ten S&P 500 dividend dogs could deliver 23% to 40% net gains by August 2026, with moderate risk. A market correction or dividend increases could make all top ten 'safer' dividend dogs attractively priced, maximizing yie...
Neutral
PRNewsWire
23 days ago
Approval is Another Milestone of Viatris' Ability to Successfully Develop Complex Generic Medicines Approval Granted with Competitive Generic Therapy Eligibility for 100mg/5mL and 200mg/10mL Strengths; Provides Eligibility for 180 Days of Exclusivity PITTSBURGH , Aug. 11, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the U.S. Food and Drug Admini...
More Viatris News

Company Profile

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Head office United States
CEO Scott Smith
Employees 32,000
Founded 2019
Website www.viatris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today